Randomized, Double-Blind, Phase III Study of Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: CONSOLE.
J Clin Oncol
; 40(2): 180-188, 2022 01 10.
Article
in En
| MEDLINE
| ID: mdl-34793245
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyridines
/
Quinuclidines
/
Vomiting
/
Morpholines
/
Cisplatin
/
Neurokinin-1 Receptor Antagonists
/
Isoquinolines
/
Antiemetics
/
Nausea
/
Antineoplastic Agents
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
J Clin Oncol
Year:
2022
Document type:
Article
Affiliation country:
Japan
Country of publication:
United States